Medtronic plc (MDT)
USD 80.03
(-1.65%)
USD 80.03
(-1.65%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 3.67 Billion USD | -2.18% |
| 2023 | 3.75 Billion USD | -25.42% |
| 2022 | 5.03 Billion USD | 39.74% |
| 2021 | 3.6 Billion USD | -24.7% |
| 2020 | 4.78 Billion USD | 3.41% |
| 2019 | 4.63 Billion USD | 49.19% |
| 2018 | 3.1 Billion USD | -22.94% |
| 2017 | 4.02 Billion USD | 13.85% |
| 2016 | 3.53 Billion USD | 32.26% |
| 2015 | 2.67 Billion USD | -12.72% |
| 2014 | 3.06 Billion USD | -11.6% |
| 2013 | 3.46 Billion USD | -4.15% |
| 2012 | 3.61 Billion USD | 16.83% |
| 2011 | 3.09 Billion USD | -0.1% |
| 2010 | 3.09 Billion USD | 42.88% |
| 2009 | 2.16 Billion USD | -2.78% |
| 2008 | 2.23 Billion USD | -20.38% |
| 2007 | 2.8 Billion USD | 10.02% |
| 2006 | 2.54 Billion USD | 41.18% |
| 2005 | 1.8 Billion USD | -7.93% |
| 2004 | 1.95 Billion USD | 22.47% |
| 2003 | 1.59 Billion USD | 62.58% |
| 2002 | 984 Million USD | -5.93% |
| 2001 | 1.04 Billion USD | -4.78% |
| 2000 | 1.09 Billion USD | 134.52% |
| 1999 | 468.4 Million USD | 2.4% |
| 1998 | 457.4 Million USD | -13.7% |
| 1997 | 530 Million USD | 21.06% |
| 1996 | 437.8 Million USD | 48.91% |
| 1995 | 294 Million USD | 26.51% |
| 1994 | 232.4 Million USD | 17.85% |
| 1993 | 197.2 Million USD | 22.11% |
| 1992 | 161.5 Million USD | 21.06% |
| 1991 | 133.4 Million USD | 22.72% |
| 1990 | 108.7 Million USD | 11.6% |
| 1989 | 97.4 Million USD | 12.6% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 654 Million USD | -50.53% |
| 2024 Q1 | 791 Million USD | -32.91% |
| 2024 Q2 | 909 Million USD | 14.92% |
| 2024 Q3 | 1.32 Billion USD | 45.43% |
| 2024 FY | 3.67 Billion USD | -2.18% |
| 2023 Q1 | 929 Million USD | -37.44% |
| 2023 Q3 | 1.22 Billion USD | 186.18% |
| 2023 Q4 | 1.17 Billion USD | -3.52% |
| 2023 Q2 | 427 Million USD | -54.04% |
| 2023 FY | 3.75 Billion USD | -25.42% |
| 2022 FY | 5.03 Billion USD | 39.74% |
| 2022 Q3 | 1.48 Billion USD | 12.89% |
| 2022 Q2 | 1.31 Billion USD | 71.82% |
| 2022 Q1 | 763 Million USD | -43.94% |
| 2022 Q4 | 1.48 Billion USD | 0.34% |
| 2021 FY | 3.6 Billion USD | -24.7% |
| 2021 Q2 | 489 Million USD | 0.41% |
| 2021 Q3 | 1.27 Billion USD | 159.71% |
| 2021 Q4 | 1.36 Billion USD | 7.17% |
| 2021 Q1 | 487 Million USD | -24.61% |
| 2020 Q2 | 1.36 Billion USD | 57.87% |
| 2020 Q3 | 1.91 Billion USD | 40.4% |
| 2020 Q1 | 864 Million USD | -26.28% |
| 2020 FY | 4.78 Billion USD | 3.41% |
| 2020 Q4 | 646 Million USD | -66.27% |
| 2019 Q1 | 1.07 Billion USD | -26.37% |
| 2019 Q2 | 1.11 Billion USD | 3.72% |
| 2019 Q3 | 1.26 Billion USD | 13.81% |
| 2019 Q4 | 1.17 Billion USD | -7.64% |
| 2019 FY | 4.63 Billion USD | 49.19% |
| 2018 Q3 | -1.38 Billion USD | -168.86% |
| 2018 FY | 3.1 Billion USD | -22.94% |
| 2018 Q1 | 1.01 Billion USD | -12.64% |
| 2018 Q2 | 2.01 Billion USD | 98.52% |
| 2018 Q4 | 1.46 Billion USD | 205.11% |
| 2017 Q2 | 1.11 Billion USD | 20.02% |
| 2017 FY | 4.02 Billion USD | 13.85% |
| 2017 Q4 | 1.16 Billion USD | 41.66% |
| 2017 Q1 | 929 Million USD | -15.85% |
| 2017 Q3 | 821 Million USD | -26.37% |
| 2016 Q3 | 1.09 Billion USD | 110.58% |
| 2016 Q4 | 1.1 Billion USD | 0.82% |
| 2016 FY | 3.53 Billion USD | 32.26% |
| 2016 Q1 | 820 Million USD | 82100.0% |
| 2016 Q2 | 520 Million USD | -36.59% |
| 2015 Q4 | -1 Million USD | -100.1% |
| 2015 FY | 2.67 Billion USD | -12.72% |
| 2015 Q2 | 828 Million USD | -4.94% |
| 2015 Q1 | 871 Million USD | 94.42% |
| 2015 Q3 | 977 Million USD | 18.0% |
| 2014 FY | 3.06 Billion USD | -11.6% |
| 2014 Q1 | 953 Million USD | -1.65% |
| 2014 Q3 | 762 Million USD | -15.52% |
| 2014 Q2 | 902 Million USD | -5.35% |
| 2014 Q4 | 448 Million USD | -41.21% |
| 2013 Q3 | 988 Million USD | 52.94% |
| 2013 Q2 | 646 Million USD | -25.23% |
| 2013 Q1 | 864 Million USD | -12.82% |
| 2013 FY | 3.46 Billion USD | -4.15% |
| 2013 Q4 | 969 Million USD | -1.92% |
| 2012 FY | 3.61 Billion USD | 16.83% |
| 2012 Q4 | 991 Million USD | 5.99% |
| 2012 Q3 | 935 Million USD | 7.35% |
| 2012 Q2 | 871 Million USD | 6.09% |
| 2012 Q1 | 821 Million USD | 5.8% |
| 2011 Q4 | 776 Million USD | -16.02% |
| 2011 FY | 3.09 Billion USD | -0.1% |
| 2011 Q2 | 566 Million USD | -31.81% |
| 2011 Q1 | 830 Million USD | -13.0% |
| 2011 Q3 | 924 Million USD | 63.25% |
| 2010 Q4 | 954 Million USD | 14.8% |
| 2010 FY | 3.09 Billion USD | 42.88% |
| 2010 Q1 | 445 Million USD | 247.66% |
| 2010 Q2 | 868 Million USD | 95.06% |
| 2010 Q3 | 831 Million USD | -4.26% |
| 2009 Q2 | 571 Million USD | -23.56% |
| 2009 Q1 | 747 Million USD | -8.12% |
| 2009 Q4 | 128 Million USD | -82.3% |
| 2009 Q3 | 723 Million USD | 26.62% |
| 2009 FY | 2.16 Billion USD | -2.78% |
| 2008 Q2 | 666 Million USD | -1.33% |
| 2008 Q4 | 813 Million USD | 955.84% |
| 2008 FY | 2.23 Billion USD | -20.38% |
| 2008 Q1 | 675 Million USD | -16.87% |
| 2008 Q3 | 77 Million USD | -88.44% |
| 2007 Q3 | 710 Million USD | 4.26% |
| 2007 FY | 2.8 Billion USD | 10.02% |
| 2007 Q1 | 599 Million USD | -19.05% |
| 2007 Q2 | 681 Million USD | 13.69% |
| 2007 Q4 | 812 Million USD | 14.37% |
| 2006 Q3 | 669.6 Million USD | -17.99% |
| 2006 Q4 | 740 Million USD | 10.51% |
| 2006 Q2 | 816.5 Million USD | 154.68% |
| 2006 Q1 | 320.6 Million USD | 64.92% |
| 2006 FY | 2.54 Billion USD | 41.18% |
| 2005 Q1 | 529.7 Million USD | -6.89% |
| 2005 Q2 | 535.7 Million USD | 1.13% |
| 2005 Q3 | 544.1 Million USD | 1.57% |
| 2005 FY | 1.8 Billion USD | -7.93% |
| 2005 Q4 | 194.4 Million USD | -64.27% |
| 2004 Q3 | 463.9 Million USD | -2.56% |
| 2004 Q2 | 476.1 Million USD | 5.71% |
| 2004 FY | 1.95 Billion USD | 22.47% |
| 2004 Q1 | 450.4 Million USD | -7.53% |
| 2004 Q4 | 568.9 Million USD | 22.63% |
| 2003 Q1 | 383.3 Million USD | 27.38% |
| 2003 Q4 | 487.1 Million USD | 13.89% |
| 2003 Q3 | 427.7 Million USD | 41.76% |
| 2003 Q2 | 301.7 Million USD | -21.29% |
| 2003 FY | 1.59 Billion USD | 62.58% |
| 2002 Q3 | 314.9 Million USD | 372.11% |
| 2002 FY | 984 Million USD | -5.93% |
| 2002 Q4 | 300.9 Million USD | -4.45% |
| 2002 Q2 | 66.7 Million USD | -77.88% |
| 2002 Q1 | 301.5 Million USD | 101.0% |
| 2001 Q3 | 302.8 Million USD | -3.6% |
| 2001 Q2 | 314.1 Million USD | 8.69% |
| 2001 Q1 | 289 Million USD | -10.3% |
| 2001 FY | 1.04 Billion USD | -4.78% |
| 2001 Q4 | 150 Million USD | -50.46% |
| 2000 Q3 | 263.2 Million USD | 2.21% |
| 2000 Q4 | 322.2 Million USD | 22.42% |
| 2000 FY | 1.09 Billion USD | 134.52% |
| 2000 Q1 | 248.9 Million USD | 57.43% |
| 2000 Q2 | 257.5 Million USD | 3.46% |
| 1999 FY | 468.4 Million USD | 2.4% |
| 1999 Q1 | 150.4 Million USD | -6.06% |
| 1999 Q2 | 145 Million USD | -3.59% |
| 1999 Q3 | -35.1 Million USD | -124.21% |
| 1999 Q4 | 158.1 Million USD | 550.43% |
| 1998 FY | 457.4 Million USD | -13.7% |
| 1998 Q4 | 160.1 Million USD | 2093.15% |
| 1998 Q1 | 146.5 Million USD | 0.69% |
| 1998 Q2 | 143.5 Million USD | -2.05% |
| 1998 Q3 | 7.3 Million USD | -94.91% |
| 1997 Q4 | 145.5 Million USD | 13.05% |
| 1997 Q3 | 128.7 Million USD | 0.31% |
| 1997 Q2 | 128.3 Million USD | 0.71% |
| 1997 Q1 | 127.4 Million USD | 1.59% |
| 1997 FY | 530 Million USD | 21.06% |
| 1996 Q2 | 104.6 Million USD | 4.91% |
| 1996 Q4 | 125.4 Million USD | 15.05% |
| 1996 Q3 | 109 Million USD | 4.21% |
| 1996 Q1 | 99.7 Million USD | 13.55% |
| 1996 FY | 437.8 Million USD | 48.91% |
| 1995 Q1 | 65.1 Million USD | -2.54% |
| 1995 Q2 | 69.7 Million USD | 7.07% |
| 1995 Q4 | 87.8 Million USD | 22.97% |
| 1995 Q3 | 71.4 Million USD | 2.44% |
| 1995 FY | 294 Million USD | 26.51% |
| 1994 Q2 | 56.2 Million USD | 7.05% |
| 1994 Q1 | 52.5 Million USD | -9.48% |
| 1994 Q3 | 56.9 Million USD | 1.25% |
| 1994 Q4 | 66.8 Million USD | 17.4% |
| 1994 FY | 232.4 Million USD | 17.85% |
| 1993 Q4 | 58 Million USD | 21.34% |
| 1993 Q3 | 47.8 Million USD | -20.6% |
| 1993 Q1 | 45.6 Million USD | -3.8% |
| 1993 Q2 | 60.2 Million USD | 32.02% |
| 1993 FY | 197.2 Million USD | 22.11% |
| 1992 Q3 | 39.4 Million USD | 2.34% |
| 1992 Q2 | 38.5 Million USD | 6.65% |
| 1992 Q1 | 36.1 Million USD | -10.42% |
| 1992 Q4 | 47.4 Million USD | 20.3% |
| 1992 FY | 161.5 Million USD | 21.06% |
| 1991 Q4 | 40.3 Million USD | 17.84% |
| 1991 Q1 | 28.8 Million USD | -7.1% |
| 1991 Q2 | 28.7 Million USD | -0.35% |
| 1991 Q3 | 34.2 Million USD | 19.16% |
| 1991 FY | 133.4 Million USD | 22.72% |
| 1990 Q4 | 31 Million USD | 14.39% |
| 1990 FY | 108.7 Million USD | 11.6% |
| 1990 Q3 | 27.1 Million USD | 3.44% |
| 1990 Q2 | 26.2 Million USD | -3.32% |
| 1990 Q1 | 27.1 Million USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 FY | 97.4 Million USD | 12.6% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 35.768% |
| Allurion Technologies Inc. | -82.3 Million USD | 4566.369% |
| Artivion, Inc. | -30.69 Million USD | 12077.843% |
| Avanos Medical, Inc. | -61.8 Million USD | 6048.22% |
| Butterfly Network, Inc. | -133.69 Million USD | 2849.439% |
| Butterfly Network, Inc. | -133.69 Million USD | 2849.439% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 676.787% |
| Boston Scientific Corporation | 1.59 Billion USD | -130.76% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | 25157.941% |
| CONMED Corporation | 64.45 Million USD | -5602.85% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | -162.122% |
| Paragon 28, Inc. | -47.84 Million USD | 7783.786% |
| Glaukos Corporation | -134.66 Million USD | 2829.818% |
| Globus Medical, Inc. | 122.87 Million USD | -2891.707% |
| Inspire Medical Systems, Inc. | -21.15 Million USD | 17478.15% |
| Integer Holdings Corporation | 90.65 Million USD | -3955.157% |
| Nevro Corp. | -92.21 Million USD | 4086.423% |
| Owlet, Inc. | -32.9 Million USD | 11272.913% |
| Penumbra, Inc. | 90.95 Million USD | -3941.603% |
| Vicarious Surgical Inc. | -71.07 Million USD | 5272.292% |
| Smith & Nephew plc | 263 Million USD | -1297.719% |
| Sonendo, Inc. | -60.91 Million USD | 6134.242% |
| STERIS plc | 378.23 Million USD | -871.872% |
| Stryker Corporation | 3.16 Billion USD | -16.145% |
| Vapotherm, Inc. | -58.19 Million USD | 6416.911% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | -258.984% |